After encouraging results from the pre-clinical trial at UAB, a new COVID-19 vaccine candidate is set to start its clinical trial this week.
Nasal Spray Vaccine In Human Testing
A new covid-19 vaccine candidate is set to start its clinical trial this week!
Waay 31's alex torres-perez tells us the f-d-a allowed the vaccine testing on humans.
That's after encouraging results from the pre-clinical trial at uab.
Ll: the altimmune vaccine is a potential game changer in the fight against the pandemic for a number of reasons.
One of them being that it's not a shot...it's a nasal spray.
Dr. sarah brown "intranasal vaccine just makes a lot of sense to block the infection of the site of introduction."
But the vaccine would not only block covid-19 from entering your body - researchers say it would also stop it from coming out -- protecting you and others from transmission.
Dr. frances lund "the more you can prevent transmission.
The more quickly you can reduce the virus infection in the community, and the more quickly you can help to control the pandemic."
Dr. frances lund was the lead researcher of the altimmune vaccine pre-clinical trial at uab.
During that trial - animals were given high doses of covid-19 -- then given the nasal vaccine.
Lund says those animals were not only able to neutralize the virus in their bodies -- but also had an additional layer of protection in their nose and upper respiratory system.
Something altimmune refers to as mucosal immunity.
The company's senior director for vaccine development says it helps stop transmission